Delova Reports Positive Phase 3 Results for Long-A...
Category : Clinical Trial Update 6 January 2026Nanjing Delova has cleared a major clinical hurdle in postoperative pain management. Two pivotal Pha...
Clinical Trial Update
MetaVia’s DA-1726 Delivers Rapid, Statistically Si...
Category : Clinical Trial Update 6 January 2026MetaVia has posted eye-catching Phase 1 data for DA-1726, its dual GLP-1/glucagon agonist, showing f...
ScinoPharm Becomes the First Taiwanese Company to...
Category : Clinical Trial Update 5 January 2026ScinoPharm Taiwan has achieved a historic milestone. The company has secured US FDA approval for Gla...
Ultragenyx’s Setrusumab Misses Primary Endpoints i...
Category : Clinical Trial Update 2 January 2026Ultragenyx’s Setrusumab Misses Primary Endpoints in Phase 3 OI Trials, Shows Bone Density Gain...
ImmunoForge Heads to JPM 2026 to Seek Global Partn...
Category : Clinical Trial Update 2 January 2026ImmunoForge Heads to JPM 2026 to Seek Global Partners for FDA-Cleared Phase 2 Assets Clinical-sta...
Latest Newsletter Post
-
Bambusa Therapeutics Doses First Pa..
7 January 2026
-
Endeavor Health Joins Trial to Diag..
7 January 2026
-
FDA Grants Priority Review to Tziel..
7 January 2026
-
MetaVia’s DA-1726 Delivers Rapid, S..
6 January 2026
-
Delova Reports Positive Phase 3 Res..
6 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com